电邮这篇文章 Rare clinical case of diffuse B-large cell lymphoma with laryngeal lesion
- 作者: Kamaeva I.A.1, Lysenko I.B.1, Engibaryan M.A.1, Gusareva M.A.1, Legostaev V.M.1, Lapteva T.O.1, Nikolaeva N.V.1, Gaysultanova Y.S.1, Kapuza E.A.1, Samaneva N.Y.1, Ulyanova Y.V.1, Volkova V.L.1, Bauzhadze M.V.1, Balizkiy G.V.1, Tolmacheva E.A.1
-
隶属关系:
- National Medical Research Centre for Oncology
- 期: 卷 27, 编号 1 (2022)
- 页面: 29-36
- 栏目: Case Reports
- ##submission.dateSubmitted##: 01.08.2022
- ##submission.dateAccepted##: 15.12.2022
- ##submission.datePublished##: 08.03.2023
- URL: https://rjonco.com/1028-9984/article/view/109580
- DOI: https://doi.org/10.17816/onco109580
- ID: 109580
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
Diffuse large B-cell lymphoma (DLBCL) is the most common variant of non-Hodgkin’s lymphoma and accounts for 30–60% of all non-Hodgkin’s lymphomas, with increasing incidence increases with age. Currently, the prognosis is assessed using the International Prognostic Index. In recent years, in all European regions, there has been a significant improvement in survival in DLBCL due to the addition of rituximab to standard chemotherapy (CHOP protocol). However, despite significant advances in treatment, long-term remission is only achieved in half of the patients. Laryngeal lesions with this variant of lymphomas is described only in a few articles. There is evidence of various chemotherapeutic regimens effective in this type of lymphoma; in some publications, the authors suggest the use of radiation therapy.
The article presents a clinical case of successful treatment of a patient (chemotherapy + radiation therapy) with diffuse large B-cell lymphoma with laryngeal involvement. with resulting remission. In addition, a review of the literature describing the most common types of lymphomas is presented. The authors set a goal to raise the awareness of physicians about a rare histological variant of laryngeal tumors with a rapid increase in clinical manifestations and the development of life-threatening conditions.
全文:
作者简介
Inna Kamaeva
National Medical Research Centre for Oncology
编辑信件的主要联系方式.
Email: inkamaeva@yandex.ru
ORCID iD: 0000-0003-3001-0675
SPIN 代码: 8953-3351
Oncologist
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonIrina Lysenko
National Medical Research Centre for Oncology
Email: iralyss@rambler.ru
ORCID iD: 0000-0003-4457-3815
SPIN 代码: 9510-3504
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonMarina Engibaryan
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
ORCID iD: 0000-0001-7293-2358
SPIN 代码: 1764-0276
MD, Dr. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonMarina Gusareva
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 9040-5476
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonVladislav Legostaev
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 6573-8672
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonTatyana Lapteva
National Medical Research Centre for Oncology
Email: lto-96@yandex.ru
SPIN 代码: 2771-3213
俄罗斯联邦, 63 14th line, 344037 Rostov-on-Don
Nadezhda Nikolaeva
National Medical Research Centre for Oncology
Email: nadya.nikolaeva.74@bk.ru
ORCID iD: 0000-0001-7224-3106
SPIN 代码: 4295-5920
MD, Dr. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonYakha Gaysultanova
National Medical Research Centre for Oncology
Email: yakha.gaysultanova@mail.ru
ORCID iD: 0000-0003-2785-1721
Oncologist
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonElena Kapuza
National Medical Research Centre for Oncology
Email: kapuzaea1967@mail.ru
ORCID iD: 0000-0002-0761-2486
SPIN 代码: 4430-1151
Oncologist
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonNatalya Samaneva
National Medical Research Centre for Oncology
Email: prettyfairy19@rambler.ru
ORCID iD: 0000-0003-0843-6012
SPIN 代码: 1181-0659
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonYulia Ulyanova
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 1276-9063
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonViktoria Volkova
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
ORCID iD: 0000-0003-2674-0755
SPIN 代码: 8289-6300
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonMamuka Bauzhadze
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 5315-3382
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-DonGennadiy Balizkiy
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 4090-2703
俄罗斯联邦, 63 14th line, 344037 Rostov-on-Don
Ekaterina Tolmacheva
National Medical Research Centre for Oncology
Email: inkamaeva@yandex.ru
SPIN 代码: 2376-0705
MD, Cand. Sci. (Med.)
俄罗斯联邦, 63 14th line, 344037 Rostov-on-Don参考
- World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. Volume 2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, et al, editors. Lyon: International agency for research on cancer; 2017.
- Ollila TA, Olszewski AJ. Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence. Curr Treat Options Oncol. 2018;19(8):38. doi: 10.1007/s11864-018-0555-8
- Zykova TA, Engibarjan MA, Pustovaja IV., i dr. Vyjavleny razlichija serologicheskogo profilja inficirovanija virusom Jepshtejna-Barr u bol’nyh s opuholjami oblasti golovy/shei i limfomami. In: Materialy V Peterburgskogo mezhdunarodnogo onkologicheskogo foruma «Belye nochi»; 2019 Jun 20–23; Saint-Petersburg. Saint-Petersburg: Avtonomnaja nekommercheskaja nauchno-medicinskaja organizacija «Voprosy onkologii»; 2019. P. 116.
- Kamaeva IA, Lysenko IB, Nikolaeva NV, et al. The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice. South Russian Journal of Cancer. 2021;2(2):34–41. doi: 10.37748/2686-9039-2021-2-2-4
- Kit OI, Kamaeva IA, Lysenko IB. Primary mediastinal large B-cell lymphoma with a rare ALK gene mutation. Advances in Molecular Oncology. 2022;9(2):105–110. doi: 10.17650/2313-805X-2022-9-2-105-110
- Sharma V, Gupta S, Patel M, et al. Diffuse large B cell lymphoma of larynx. J Assoc Physicians India. 2018;66(5):91–93.
- Zhao P, Zhou Y, Li J. Primary laryngeal lymphoma in China: a retrospective study of the last 25 years. J Laryngol Otol. 2019;133(9):792–795. doi: 0.1017/S0022215119001622
- Horny HP. The larynx in lymphoproliferative and myeloproliferative diseases. Part II: Laryngeal autopsy findings and discussion. HNO. 1994;42(7):398–404. (In German).
- Ng C, Mentias Y, Abdelgalil A. Imaging features of non-epithelial tumours of the larynx. Clin Radiol. 2020;75(9):711.e5–711.e12. doi: 10.1016/j.crad.2020.01.013
- Belousova NV, Poddubnyj BK, Ungiadze GV, et al. Jendoskopicheskaja semiotika i diagnostika limfom glotochnogo kol’ca Pirogova–Val’dejera. Journal of Modern Oncology. 2005;7(3):118–121.
- Kato S, Sakura M, Takooda S, et al. Primary non-Hodgkin’s lymphoma of the larynx. J Laryngol Otol. 1997;111(6):571–574. doi: 10.1017/s0022215100137946
- Andratschke M, Stelter K, Ihrler S, Hagedorn H. Subglottic tracheal stenosis as primary manifestation of a marginal zone B-cell lymphoma of the larynx. In Vivo. 2005;19(3):547–550.
- Chaker K, Beghdad M, Mennouni MA, Mkhatri A, et al. Primary laryngeal T-cell lymphoma: a case report and review of the literature. Int J Surg Case Rep. 2021;82:105858. doi: 10.1016/j.ijscr.2021.105858
- Liu D, Qian T, Sun S, Jiang JJ. Laryngopharyngeal reflux and inflammatory responses in mucosal barrier dysfunction of the upper aerodigestive tract. J Inflamm Res. 2021;13:1291–1304. doi: 10.2147/JIR.S282809
- Johnson AO, Stevens BP, Lam JT, Schweinfurth JM. Two cases of rare subglottic MALT lymphoma of the larynx. Am J Otolaryngol. 2020;41(6):102736. doi: 10.1016/j.amjoto.2020.102736
- Franzen A. Kurrer MO. Malignant lymphoma of the larynx: a case report and review of the literature. Laryngorhinootologie. 2000;79(10):579–583. (In German). doi: 10.1055/s-2000-7678
补充文件
